- Top Workplaces
- Dyax Corp.
Dyax Corp.
Dyax's mission is to develop and commercialize innovative biopharmaceuticals for unmet medical needs while delivering value to patients, shareholders
and employees. The Company works to fulfill this mission by marketing KALBITOR® (ecallantide), its FDA approved product for the rare disease
hereditary angioedema (HAE), and through its commitment to developing DX-2930, a potential prophylactic treatment for HAE. Dyax is also working to
identify and develop additional treatments for other rare disorders. Both KALBITOR and DX-2930 were identified using Dyax's proprietary phage display
technology. Dyax has broadly licensed this technology under its Licensing and Funded Research Portfolio (LFRP). The current portfolio inclu... Read more
and employees. The Company works to fulfill this mission by marketing KALBITOR® (ecallantide), its FDA approved product for the rare disease
hereditary angioedema (HAE), and through its commitment to developing DX-2930, a potential prophylactic treatment for HAE. Dyax is also working to
identify and develop additional treatments for other rare disorders. Both KALBITOR and DX-2930 were identified using Dyax's proprietary phage display
technology. Dyax has broadly licensed this technology under its Licensing and Funded Research Portfolio (LFRP). The current portfolio inclu... Read more
Recent Awards
2015
2014
2008